![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Awantani K A, Cheung A P. Metformin and polycystic ovary syndrome: a literature review. Journal of Obstetrics and Gynaecology Canada 2002; 24: 393–401
- De Sloover Koch Y, Ernst M E. Use of metformin in polycystic ovary syndrome. The Annals of Pharmacotherapy 2001; 35: 1644–1647
- Ramsay I D, Rushton D H. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia. Clinical and Experimental Dermatology 1990; 15: 277–281
- Stadtmauer L A, Wong B C, Oehninger S. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitising drugs in polycystic ovary syndrome, beyond ovulation induction. Human Reproduction 2002; 17: 3016–3026